BioPharmSignal logoBioPharmSignal

Biotech News

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

Xtant Medical (XTNT)Xtant MedicalEarnings

BELGRADE, Mont., May 7, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that it will release its financial results for the first quarter ended March 31,

Open original release

Related news

XTNTXtant Medical2026-03-25 12:00 EST

Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

XTNTXtant Medical2026-05-13 11:00 EST

Xtant Medical Reports First Quarter 2026 Financial Results

HYPRHyperfine2026-04-28 20:05 EST

Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026

ATRCAtriCure2026-04-14 12:00 EST

AtriCure to Announce First Quarter 2026 Financial Results

ICCMIceCure Medical2026-05-06 12:30 EST

IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026

IRIXIRIDEX2026-05-05 20:05 EST

Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

CVRXCVRx2026-04-27 20:30 EST

CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026

OMOutset Medical2026-04-27 20:05 EST

Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

TMCITreace Medical Concepts2026-04-24 11:05 EST

Treace to Report First Quarter 2026 Financial Results on May 8, 2026

RXSTRxSight2026-04-22 20:10 EST

RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

View all latest news

Xtant Medical

Xtant Medical is a spinal and biologics medical device company focused on bone grafts, biologics, and reconstructive products. Its business is centered on procedure-linked orthopedic care.

Recent company news

XTNTXtant Medical2026-05-13 11:00 EST

Xtant Medical Reports First Quarter 2026 Financial Results

XTNTXtant Medical2026-05-07 12:00 EST

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

XTNTXtant Medical2026-05-06 12:00 EST

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

XTNTXtant Medical2026-04-13 13:04 EST

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

XTNTXtant Medical2026-04-09 12:00 EST

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Stock data

Close
0.44 USD
Market cap
65.22M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States